IVVD

Invivyd

0.8938

+0.0394+4.61%

After Hours: 0.9159 +0.0221 +2.47%19:47 07/02 EDT

Daily

Weekly

Monthly

Quarterly

Yearly

OPEN/PREV CLOSE0.8394/0.8544

TODAY RANGE0.8394-0.9068

VOL2.20M

MARKET CAP263.32M

52 WEEK RANGE0.4830-3.070

AVG VOL (3M)4.38M

% TURNOVER0.75%

TURNOVER--

P/E (TTM)-2.5022

% RANGE7.89%

EPS(TTM)-0.3572

P/E(FORWARD)-1.8621

P/B1.245

BVPS0.7180

DIVIDEND--

P/S4.717

BETA--

DIV YIELD0.00%

FREE FLOAT MKT CAP225.96M

SHARES OUTSTANDING294.61M

NEXT EARNINGS08/12-08/17

FREE FLOAT252.81M

LOT SIZE1

EX-DATE--

News

Press Releases

Financial Reports

Profile

PUBT·2d ago
Invivyd grants 493,000 stock options to 14 new hires at $0.85 per share
Reuters·5d ago
NOVABRIDGE BIOSCIENCES APPOINTS DR. SRISHTI GUPTA AS CHIEF EXECUTIVE OFFICER
PUBT·06/16 18:27
Invivyd posts CANOPY older-adult subgroup analysis presentation on pemivibart for COVID-19 prevention
NASDAQ·06/16 14:09
Invivyd Completes Enrollment In Phase 3 LIBERTY Trial Of VYD2311 For COVID-19
TipRanks·06/16 11:37
Invivyd completes enrollment of LIBERTY clinical trial
PUBT·06/16 11:03
Invivyd completes enrollment in Phase 3 LIBERTY trial of VYD2311 antibody vs mRNA COVID vaccine
Reuters·06/16 11:01
INVIVYD - TO REPORT LIBERTY STUDY RESULTS IN Q3 2026
TipRanks·06/15 10:22
Analysts Offer Insights on Healthcare Companies: Brainsway (BWAY), Rezolute (RZLT) and Invivyd (IVVD)
TipRanks·06/12 11:40
Analysts’ Top Healthcare Picks: Enliven Therapeutics (ELVN), Invivyd (IVVD)
NASDAQ·06/10 11:04
Invivyd Doses First Participant In Phase 3 LIBERTY Trial Of VYD2311 In COVID-19
Dow Jones·06/09 16:57
Invivyd Price Target Maintained With a $10.00/Share by BTIG
PUBT·06/09 11:02
Invivyd doses first participants in Phase 3 LIBERTY trial of VYD2311 vs mRNA COVID vaccine
Reuters·06/09 11:01
INVIVYD - EXPECTS LIBERTY TRIAL TOPLINE DATA IN Q3 2026
PUBT·06/03 11:05
Invivyd grants new hires options for 513,500 shares at $1.22 each under inducement plan
Reuters·06/03 11:01
INVIVYD REPORTS INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)

Same Industry

Name/Symbol

Change%

Price

McKesson

MCK

+2.37%

786.30

Biogen Inc

BIIB

+6.97%

216.03

Amgen Inc

AMGN

+0.44%

362.12

Shire

SHPG

0.00%

179.20

CELG-RT

Lilly Eli & Co

LLY

+7.13%

CELG

Therapeuticsmd Inc

TXMD

+1.43%

2.191

Johnson & Johnson

JNJ

+2.70%

260.83

ABBV

Zoetis Inc

ZTS

-1.90%

71.86

Gilead Sciences Inc

GILD

+0.01%

126.34

Novo-Nordisk A/S

NVO

-0.83%

47.94

BMY

Alexion Pharms

ALXN

+1.70%

182.50

Pfizer

PFE

+2.45%

24.47

SNY

Sanofi FR

GCVRZ

0.00%

0.8711

Novartis

NVS

-1.65%

154.14

RDY

No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.